Literature DB >> 9989816

Two novel regions of interstitial deletion on chromosome 8p in colorectal cancer.

S A Chughtai1, M C Crundwell, N R Cruickshank, E Affie, S Armstrong, M A Knowles, L A Takle, M Kuo, N Khan, S M Phillips, J P Neoptolemos, D G Morton.   

Abstract

We have investigated interstitial deletions of chromosome 8 in 70 colorectal carcinomas and 11 colonic adenomas using 11 microsatellite markers, including eight spanning the centromeric region of chromosome 8p (p11.2-p12). Allelic loss or imbalance was observed in 38 (54%) cancers and four (36%) adenomas. Twenty-eight (40%) of the cancers had deletions of 8p11.2-p12. Two distinct and independent regions of interstitial loss were found within this region. Fluorescent in situ hybridization, using an alpha satellite repeat probe to the centromere of 8p and two probes to the P1 region, was performed in four tumours that demonstrated allelic imbalance. Localized heterozygous deletions were confirmed in all four tumours. Eleven (16%) cancers had localized deletion in the region ANK-1 to D8S255 (P1) and a further eleven (16%) cancers had a less well localized deletion in the region defined by the markers D8S87 to D8S259 (P2). Loss of both centromeric loci was identified in a further six (9%) tumours. A functional significance for these two deletion regions was sought by correlation with primary and secondary tumour characteristics. Isolated P2 deletion was associated with 'early' T1 cancers (2p=0.0002), and were also identified in 3/11 adenomas. Conversely, interstitial deletions of the P1 locus were more frequently seen in 'locally invasive' T3/4 cancers (2p=0.015), and isolated P1 deletions were also associated with the presence of liver metastases (2p=0.016). Our data provide evidence of at least two genes within the 8p11.2-p12 region, mutations in which may confer different and independent roles in the pathogenesis of colorectal cancer.

Entities:  

Mesh:

Year:  1999        PMID: 9989816     DOI: 10.1038/sj.onc.1202340

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  12 in total

1.  Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer.

Authors:  Ruben Agrelo; Wen-Hsing Cheng; Fernando Setien; Santiago Ropero; Jesus Espada; Mario F Fraga; Michel Herranz; Maria F Paz; Montserrat Sanchez-Cespedes; Maria Jesus Artiga; David Guerrero; Antoni Castells; Cayetano von Kobbe; Vilhelm A Bohr; Manel Esteller
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-24       Impact factor: 11.205

2.  Werner syndrome as a hereditary risk factor for exocrine pancreatic cancer: potential role of WRN in pancreatic tumorigenesis and patient-tailored therapy.

Authors:  Stephen G Chun; Nelson S Yee
Journal:  Cancer Biol Ther       Date:  2010-09-22       Impact factor: 4.742

Review 3.  RecQ Helicase Somatic Alterations in Cancer.

Authors:  Megha K Thakkar; Jamie Lee; Stefan Meyer; Vivian Y Chang
Journal:  Front Mol Biosci       Date:  2022-06-15

4.  WRN Cys1367Arg SNP is not associated with risk and prognosis of gliomas in Southeast Brazil.

Authors:  Giovanny R Pinto; France K N Yoshioka; Carlos A Clara; Marcelo J Santos; José R W Almeida; Rommel R Burbano; Juan A Rey; Cacilda Casartelli
Journal:  J Neurooncol       Date:  2008-08-01       Impact factor: 4.130

5.  Genetic and epigenetic inactivation of TNFRSF10C in human prostate cancer.

Authors:  Yu Cheng; Jin Woo Kim; Wennuan Liu; Thomas A Dunn; Jun Luo; Matthew J Loza; Seong-Tae Kim; Siqun Lilly Zheng; Jianfeng Xu; William B Isaacs; Bao-Li Chang
Journal:  Prostate       Date:  2009-02-15       Impact factor: 4.104

6.  TNFRSF10C copy number variation is associated with metastatic colorectal cancer.

Authors:  Daniel G Tanenbaum; William A Hall; Lauren E Colbert; Amanda J Bastien; Daniel J Brat; Jun Kong; Sungjin Kim; Bhakti Dwivedi; Jeanne Kowalski; Jerome C Landry; David S Yu
Journal:  J Gastrointest Oncol       Date:  2016-06

7.  Down-regulation of Lsm1 is involved in human prostate cancer progression.

Authors:  S Takahashi; S Suzuki; S Inaguma; Y-M Cho; Y Ikeda; N Hayashi; T Inoue; Y Sugimura; N Nishiyama; T Fujita; T Ushijima; T Shirai
Journal:  Br J Cancer       Date:  2002-03-18       Impact factor: 7.640

8.  Association of epigenetic inactivation of the WRN gene with anticancer drug sensitivity in cervical cancer cells.

Authors:  Kenta Masuda; Kouji Banno; Megumi Yanokura; Kosuke Tsuji; Yusuke Kobayashi; Iori Kisu; Arisa Ueki; Wataru Yamagami; Hiroyuki Nomura; Eiichiro Tominaga; Nobuyuki Susumu; Daisuke Aoki
Journal:  Oncol Rep       Date:  2012-07-13       Impact factor: 3.906

9.  Systematic genomic identification of colorectal cancer genes delineating advanced from early clinical stage and metastasis.

Authors:  Hojoon Lee; Patrick Flaherty; Hanlee P Ji
Journal:  BMC Med Genomics       Date:  2013-12-05       Impact factor: 3.063

10.  TNFRSF10C methylation is a new epigenetic biomarker for colorectal cancer.

Authors:  Cong Zhou; Ranran Pan; Haochang Hu; Bin Li; Jie Dai; Xiuru Ying; Hang Yu; Jie Zhong; Yiyi Mao; Yihan Zhang; Dongping Wu; Shiwei Duan
Journal:  PeerJ       Date:  2018-09-13       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.